BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Dec 8, 2017
Targets & Mechanisms

Pathways emerging from ASH

An analysis of emerging targets at ASH by mechanism
BioCentury | Jan 18, 2016
Company News

Tensha Therapeutics, Roche deal

BioCentury | Jan 12, 2016
Company News

Roche BETs on Tensha

BioCentury | Jan 5, 2015
Product Development

BETting early

Why Index-led syndicate favored quicker exit for cancer play Oncoethix
BioCentury | Sep 6, 2012
Distillery Therapeutics

Indication: Endocrine/metabolic disease

BioCentury | Sep 6, 2012
Cover Story

New home for bromodomains

BioCentury | Sep 13, 2011
Financial News

HealthCare Ventures BETs on Tensha's bromodomains

BioCentury | Sep 12, 2011
Emerging Company Profile

Tensha: Epigenetic BET

Tensha developing bromodomain inhibitors for cancer, inflammation
Items per page:
1 - 8 of 8